EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Quantification of Enzyme–Inhibitor Pharmacological Actions

Patrick Masson iD, Tatiana Pashirova iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219565 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Patrick Masson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya St., 420008 Kazan, Russia. Hauptthemen laut MEDLINE: Enzyme Inhibitors, Enzymes. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantitative measurement of enzyme–drug interactions has become a key step in the process of drug discovery. More and more studies refer to the determination of the operational index, IC50, the half-maximal inhibitory concentration, from dose–response curves, instead of the determination of the exact dissociation constant, Ki, a true thermodynamic parameter that measures the affinity and provides information on binding mechanisms. Although knowledge of IC50 is useful for rapid screening and comparison of new molecules, it depends on experimental conditions, in particular substrate and enzyme concentration, type of inhibitor, and incubation time with inhibitor. Thus, IC50 values can be misleading in cases of allosteric inhibition, partial inhibition, slow-tight binding and progressive inhibition (covalent inhibition). As a consequence, the relationships between IC50 and Ki strongly depend on catalytic and inhibition mechanistic models and experimental conditions. The present review provides relationships between IC50 and Ki for simple and complex mechanisms of enzyme inhibition and highlights the interest of a thorough analysis of binding processes and irreversible reactions with inhibitors to describe the potentialities of new pharmacologically active compounds, acting either on Michaelian or non-Michaelian enzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enzyme InhibitorsEnzymesHumansInhibitory Concentration 50Allosteric RegulationAnimalsProtein BindingDrug Discovery

Stichwörter der Autor:innen

allosteric inhibitorhalf maximal inhibitory concentration (IC50)inhibition constant (Ki)irreversible inhibitorreversible inhibitorslow-binding inhibitortight-binding inhibitor

Substanzen

Enzyme InhibitorsEnzymes

Autor:innen und Institutionen

  • Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya St., 420008 Kazan, Russia.
  • Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of RAS, Arbuzov Str. 8, 420088 Kazan, Russia.

ORCID-Profile: Patrick Masson, Tatiana Pashirova

Zitieren

APA

Masson, P., & Pashirova, T. (2026). Quantification of Enzyme–Inhibitor Pharmacological Actions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219565

Vancouver

Masson P, Pashirova T. Quantification of Enzyme–Inhibitor Pharmacological Actions. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219565

BibTeX
@article{Masson2026,
  author = {Masson, Patrick and Pashirova, Tatiana},
  title = {Quantification of Enzyme–Inhibitor Pharmacological Actions},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219565}
}
Kostenlos starten →